The Flu Vaccine and Cardiac Mortality in Brazil
DOI:
https://doi.org/10.53843/bms.v10i14.1018Keywords:
Influenza vaccination, Cardiovascular mortality, Myocardial infarction, Public health, Ecological studyAbstract
Introduction: Influenza is linked to cardiovascular risks, such as myocardial infarction (MI), due to systemic inflammation. In Brazil, influenza vaccination is universal, but its population-level impact on cardiovascular outcomes remains understudied. Methods: An ecological study using secondary data (2009-2022) from Brazil’s five regions. Statistical models (beta and linear) assessed the association between vaccine coverage (doses/100,000 inhabitants) and in-hospital mortality, costs, length of stay, and hospitalization rates for MI/revascularization. Results: No significant association was found between vaccine coverage and mortality (MI: β = 4.8×10⁻⁶; p = 0.613; revascularization: β = 9.5×10⁻⁶; p = 0.576), length of stay, or hospitalization rates. Temporal reductions in MI mortality were significant (β = -0.0325; p < 0.001), likely tied to clinical advancements. Discussion: The lack of association contrasts with clinical trials [4], suggesting contextual factors (regional disparities, care quality) modulate outcomes. Conclusion: Influenza vaccination did not directly impact the analyzed outcomes, but integrated policies addressing regional disparities are critical for cardiovascular health.
References
1. World Health Organization. Influenza (Seasonal). Geneva: WHO; 2022. Disponível em: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal).
2. Kwong JC, Schwartz KL, Campitelli MA, et al. Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. N Engl J Med. 2018;378(4):345-353.
3. Ribeiro ALP, Duncan BB, Brant LCC, et al. Cardiovascular Health in Brazil: Trends and Perspectives. Circulation. 2016;133(4):422-433.
4. Udell JA, Zawi R, Bhatt DL, et al. Association Between Influenza Vaccination and Cardiovascular Outcomes in High-Risk Patients: A Meta-Analysis. JAMA. 2013;310(16):1711-1720.
5. Donalisio MR, Freitas ARR, Zöllner MSAA. Cobertura vacinal contra influenza e mortalidade por doenças respiratórias em idosos no Brasil. Cad Saúde Pública. 2017;33(5):e00111416 .
6. Ministério da Saúde (BR). Boletim Epidemiológico do Programa Nacional de Imunizações. Brasília: Ministério da Saúde; 2022.
7. Barnes M, Sax PE, Bloom DE. The Economic Burden of Influenza-Associated Hospitalizations in the United States. Health Aff (Millwood). 2020;39(2):284-291.
8. Omidi F, Zangiabadian M, Shahidi Bonjar AH, et al. Influenza vaccination and major cardiovascular risk: a systematic review and meta-analysis of clinical trials studies. Sci Rep. 2023;13:20235.
9. MacIntyre CR, Mahimbo A, Moa AM, et al. Influenza Vaccine as a Coronary Intervention for Prevention of Myocardial Infarction. Heart. 2016;102(24):1953-1956.
10. Warren-Gash C, Blackburn R, Whitaker H, et al. Laboratory-Confirmed Respiratory Infections as Triggers for Acute Myocardial Infarction and Stroke: A Self-Controlled Case Series Analysis of National Linked Datasets from Scotland. Eur Respir J. 2018;51(3):1701794.
11. Lima-Costa MF, Mambrini JVM, Andrade FB, et al. Desigualdades socioeconômicas na cobertura da vacinação contra influenza em idosos no Brasil. Rev Saúde Pública. 2019;53:34.
12. Ribeiro ALP, Duncan BB, Brant LCC, et al. Trends in Cardiovascular Disease Mortality in Brazil: 1996 to 2016. Arq Bras Cardiol. 2019;113(5):997-1004.
13. Gaglia MA, Torguson R, Waksman R. Cost-effectiveness of Intravascular Ultrasound in Percutaneous Coronary Intervention. Cardiovasc Revasc Med. 2020;21(1):146-149.
14. Nichol KL, Nordin JD, Nelson DB, et al. Effectiveness of Influenza Vaccine in the Community-Dwelling Elderly. N Engl J Med. 2007;357(14):1373-1381.
15. Osterholm MT, Kelley NS, Sommer A, et al. Efficacy and Effectiveness of Influenza Vaccines: A Systematic Review and Meta-Analysis. Lancet Infect Dis. 2012;12(1):36-44.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Gabriel Kaleb Martins, Maria Rayane Félix Pacífico, Tamyres Tavares Santos, Shantala Lua
This work is licensed under a Creative Commons Attribution 4.0 International License.
User licenses define how readers and the general public can use the article without needing other permissions. The Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders can use to share original works of authorship and other material subjects to copyright and certain other rights specified in the public license available at https:// creativecommons.org/licenses/by/4.0/deed.pt_BR. Using the 4.0 International Public License, Brazilian Medical Students (BMS) grants the public permission to use published material under specified terms and conditions agreed to by the journal. By exercising the licensed rights, authors accept and agree to abide by the terms and conditions of the Creative Commons Attribution 4.0 International Public License.
How to Cite
